Recent Updates of Immunotherapy for Allergic Rhinitis in Children.

IF 0.4 Q4 OTORHINOLARYNGOLOGY

Current Otorhinolaryngology Reports Pub Date : 2023-01-01 DOI:10.1007/s40136-023-00440-x

Chih-Feng Lin, Yi-Tsen Lin, Chun-Kang Liao, Te-Huei Yeh

{"title":"Recent Updates of Immunotherapy for Allergic Rhinitis in Children.","authors":"Chih-Feng Lin, Yi-Tsen Lin, Chun-Kang Liao, Te-Huei Yeh","doi":"10.1007/s40136-023-00440-x","DOIUrl":null,"url":null,"abstract":"Purpose of review: Allergen immunotherapy (AIT) is a novel treatment approach with disease-modifying and preventative benefits that are not shared with other strategies for treating allergic illnesses. It has been demonstrated to be safe and effective in children. This review provides the most recent information on AIT in children as well as any pertinent updates.Recent findings: Although there is not a standard way to begin AIT, there are clear indications for AIT. Each case needs to be evaluated on its own by weighing the pros and downsides. AIT has been proven to significantly improve symptoms and quality of life in children with allergic illness, reduce medication use, stop the development of new allergen sensitizations, and stop the progression of allergic rhinitis to asthma. Novel approaches are under investigation to overcome some known AIT disadvantages.Summary: This review provides a thorough summary of the most recent research and updates on AIT in children.","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"37-43"},"PeriodicalIF":0.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880370/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Otorhinolaryngology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40136-023-00440-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Purpose of review: Allergen immunotherapy (AIT) is a novel treatment approach with disease-modifying and preventative benefits that are not shared with other strategies for treating allergic illnesses. It has been demonstrated to be safe and effective in children. This review provides the most recent information on AIT in children as well as any pertinent updates.

Recent findings: Although there is not a standard way to begin AIT, there are clear indications for AIT. Each case needs to be evaluated on its own by weighing the pros and downsides. AIT has been proven to significantly improve symptoms and quality of life in children with allergic illness, reduce medication use, stop the development of new allergen sensitizations, and stop the progression of allergic rhinitis to asthma. Novel approaches are under investigation to overcome some known AIT disadvantages.

Summary: This review provides a thorough summary of the most recent research and updates on AIT in children.

Abstract Image

查看原文本刊更多论文

儿童变应性鼻炎免疫治疗最新进展。

综述目的:过敏原免疫疗法(AIT)是一种新型的治疗方法，具有其他治疗过敏性疾病的策略所不具有的疾病改善和预防作用。它已被证明对儿童是安全有效的。这篇综述提供了儿童AIT的最新信息以及任何相关的更新。最近的研究发现:虽然没有一个标准的方法来开始AIT，但有明确的适应症。每个案例都需要通过权衡利弊来进行评估。AIT已被证明能显著改善过敏性疾病儿童的症状和生活质量，减少药物使用，阻止新的过敏原致敏的发展，并阻止变应性鼻炎向哮喘的发展。新的方法正在研究中，以克服一些已知的在台投资的缺点。摘要:本文综述了儿童AIT的最新研究和最新进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Otorhinolaryngology Reports Medicine-Surgery

CiteScore

1.00

自引率

16.70%

发文量

期刊介绍： This journal aims to offer expert review articles on the most significant recent developments in the field of otorhinolaryngology. By providing clear, insightful, balanced contributions, the journal intends to serve all those involved in the diagnosis and treatment of ear, nose, throat, and head and neck disorders. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include chronic rhinosinusitis; implantable devices; neurolaryngology; otolaryngic allergy; robotic surgery; sleep apnea; skull base surgery; thyroid surgery; and quality and outcomes.